
    
      Subjects who provide voluntary written informed consent will be screened for eligibility.
      Subjects meeting all of the inclusion and none of the exclusion criteria will be eligible to
      participate.

      Eligible subjects will be randomized at the Baseline visit to receive one of the three study
      treatments three times daily for a period of 24 weeks. Each subject will return to the study
      clinic for assessment and required study procedures on Day 7, 14 and 28 and every 4 weeks
      thereafter until Week 24.
    
  